Amryt Pharma Holdings Ltd
LSE:AMYT

Watchlist Manager
Amryt Pharma Holdings Ltd Logo
Amryt Pharma Holdings Ltd
LSE:AMYT
Watchlist
Price: 143 GBX -11.73%
Market Cap: 457.1m GBX

Intrinsic Value

AMYT price has not been updated for more than 1 year. This may indicate that the stock has been delisted.

There is not enough data to reliably calculate the intrinsic value of AMYT.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AMYT Intrinsic Value
Not Available
Base Case Scenario
Compare AMYT to

Fundamental Analysis

Amryt Pharma Holdings Ltd
LSE:AMYT
UK
Pharmaceuticals
Market Cap
453.2m GBX
IPO
Apr 27, 2007
UK
Pharmaceuticals
Market Cap
453.2m GBX
IPO
Apr 27, 2007
Price
GBX
$
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AMYT?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Amryt Pharma Holdings Ltd

Current Assets 276.8m
Cash & Short-Term Investments 123.2m
Receivables 52.8m
Other Current Assets 100.8m
Non-Current Assets 578.7m
PP&E 8.4m
Intangibles 488.7m
Other Non-Current Assets 81.5m
Current Liabilities 153.8m
Other Current Liabilities 153.8m
Non-Current Liabilities 395.6m
Long-Term Debt 200.6m
Other Non-Current Liabilities 195m
Efficiency

Free Cash Flow Analysis
Amryt Pharma Holdings Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Amryt Pharma Holdings Ltd

Revenue
210.2m USD
Cost of Revenue
-106.8m USD
Gross Profit
103.4m USD
Operating Expenses
-126.8m USD
Operating Income
-23.3m USD
Other Expenses
-64.2m USD
Net Income
-87.5m USD
Fundamental Scores

AMYT Profitability Score
Profitability Due Diligence

Amryt Pharma Holdings Ltd's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
Sustainable 3Y Average Gross Margin
Declining Gross Margin
Declining Operating Margin
22/100
Profitability
Score

Amryt Pharma Holdings Ltd's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

AMYT Solvency Score
Solvency Due Diligence

Amryt Pharma Holdings Ltd's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
37/100
Solvency
Score

Amryt Pharma Holdings Ltd's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AMYT Price Targets Summary
Amryt Pharma Holdings Ltd

There are no price targets for AMYT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for AMYT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y